US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SpyGlass Pharma, Inc.

26.10

-0.3200-1.21%

Post-market: 26.100.00000.00%19:30 EDT

Volume:64.81K

Turnover:1.69M

Market Cap:869.58M

PE:-15.57

High:26.66

Open:26.42

Low:25.53

Close:26.42

52wk High:32.44

52wk Low:17.06

Shares:33.32M

Float Shares:10.78M

Volume Ratio:0.90

T/O Rate:0.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6760

EPS(LYR):-17.9825

ROE:-67.71%

ROA:-37.23%

PB:3.74

PE(LYR):-1.45

Loading ...

Overview Company News Filings

Spyglass Pharma Inc: Q4 Net Loss $5.72 per Basic and Diluted Share

THOMSON REUTERS

SpyGlass Pharma FY2025 net loss widened 36.64% to $39.9 million; loss per share widened to $17.98

Press Release: SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update

SpyGlass Pharma: Differentiated BIM-IOL Platform and Favorable Risk-Reward Support Buy Rating Ahead of 2028 NDA Catalyst

Jefferies Remains a Buy on SpyGlass Pharma (SGP)

SpyGlass Pharma Initiated at Buy by HC Wainwright & Co.

De‑Risking Milestone and Pipeline Catalysts Underpin High‑Risk Buy on SpyGlass Pharma

SpyGlass Pharma initiated with a Buy at H.C. Wainwright

Spyglass Pharma, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS

Spyglass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative Bim-Iol System

THOMSON REUTERS

SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System

SpyGlass Pharma to Host 1x1 Meetings at Jefferies Biotech on the Bay Summit in Miami Beach

SpyGlass Pharma Initiated at Buy by Jefferies

SpyGlass Pharma: De-risked BIM-IOL Platform Poised to Reshape Glaucoma Treatment and Drive Upside to Conservative Peak Sales Estimates

Leerink Initiates at Outperform With $42 Price Target

MT Newswires Live

Jefferies Initiates SpyGlass Pharma at Buy With $62 Price Target

MT Newswires Live

SpyGlass Pharma initiated with a Buy at Citi

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/SGP/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","market":"US","secType":"STK","nameCN":"SpyGlass Pharma, Inc.","latestPrice":26.1,"timestamp":1788206400000,"preClose":26.42,"halted":0,"volume":64812,"hourTrading":{"tag":"盘后","latestPrice":26.1,"preClose":26.1,"latestTime":"19:30 EDT","volume":220,"amount":5742,"timestamp":1788219003341,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012112036336109019,"floatShares":10781300,"shares":33317414,"eps":-1.676,"marketStatus":"Not Yet Opened","change":-0.32,"latestTime":"08-31 16:00:00 EDT","open":26.42,"high":26.655,"low":25.53,"amount":1693982.1703199998,"amplitude":0.042581,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.676,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":26.42,"preHourTrading":{"tag":"盘前","latestPrice":26.26,"preClose":26.42,"latestTime":"04:01 EDT","volume":4,"amount":105.04,"timestamp":1788163310674,"change":-0.16,"changeRate":-0.006056,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":26.1,"preClose":26.1,"latestTime":"19:30 EDT","volume":220,"amount":5742,"timestamp":1788219003341,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.898278},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","floatShares":10781300,"roa":"-37.23%","roe":"-67.71%","lyrEps":-17.982467,"volumeRatio":0.898278,"shares":33317414,"dividePrice":0,"high":26.655,"amplitude":0.042581,"preClose":26.42,"low":25.53,"week52Low":17.06,"pbRate":"3.74","week52High":32.44,"institutionHeld":0,"latestPrice":26.1,"eps":-1.676,"divideRate":0,"volume":64812,"delay":0,"ttmEps":-1.676,"open":26.42,"prevYearClose":16,"prevWeekClose":26.42,"prevMonthClose":22.53,"prevQuarterClose":22.26,"fiveDayClose":26.26,"twentyDayClose":22.68,"sixtyDayClose":19.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"SGP","fiscalQuarterEnding":"2026/06","expectedEps":-0.48,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2026-05-14","symbol":"SGP","fiscalQuarterEnding":"2026/03","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.69},{"market":"US","date":"2026-03-26","symbol":"SGP","fiscalQuarterEnding":"2025/12","expectedEps":-6.61,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-5.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1786939200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SGP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SGP","date":"2026-08-28","current":-15.572792,"percent":0.519231,"low":-21.652266,"twenty":-19.737842,"median":-16.133919,"eighty":-15.15457,"high":-14.017506,"avg":-16.993403,"sd":2.151838,"marketCap":900754074},"quantilePoints":[{"date":"2026-04-02","current":-20.423828,"twenty":-20.915203,"median":-19.976743,"eighty":-19.275615,"marketCap":814277598},{"date":"2026-04-10","current":-17.791054,"twenty":-19.887327,"median":-18.894548,"eighty":-18.2941,"marketCap":709311539},{"date":"2026-04-17","current":-20.985395,"twenty":-20.628232,"median":-19.259819,"eighty":-18.2941,"marketCap":836666721},{"date":"2026-04-24","current":-19.811622,"twenty":-20.628232,"median":-20.01284,"eighty":-18.750195,"marketCap":789869541},{"date":"2026-05-01","current":-19.233119,"twenty":-20.557806,"median":-19.76551,"eighty":-18.750195,"marketCap":766805217},{"date":"2026-05-08","current":-21.287223,"twenty":-20.628232,"median":-20.01284,"eighty":-18.869002,"marketCap":848700282},{"date":"2026-05-15","current":-20.348204,"twenty":-20.557806,"median":-19.991879,"eighty":-18.951807,"marketCap":811262538},{"date":"2026-05-22","current":-16.428664,"twenty":-20.542715,"median":-19.82839,"eighty":-18.248826,"marketCap":737055581},{"date":"2026-05-29","current":-16.634049,"twenty":-20.51924,"median":-19.719397,"eighty":-17.334564,"marketCap":663182890},{"date":"2026-06-05","current":-16.323837,"twenty":-20.485703,"median":-19.406541,"eighty":-16.365768,"marketCap":650815064},{"date":"2026-06-12","current":-15.166832,"twenty":-20.465581,"median":-18.98998,"eighty":-15.765344,"marketCap":604686416},{"date":"2026-06-18","current":-15.259057,"twenty":-20.45723,"median":-18.830682,"eighty":-15.591067,"marketCap":608363337},{"date":"2026-06-26","current":-14.017506,"twenty":-20.408703,"median":-18.172531,"eighty":-15.533886,"marketCap":628881407},{"date":"2026-07-02","current":-14.509349,"twenty":-20.348204,"median":-17.531147,"eighty":-15.527136,"marketCap":650947421},{"date":"2026-07-10","current":-14.956478,"twenty":-20.239211,"median":-16.634049,"eighty":-15.359666,"marketCap":671007434},{"date":"2026-07-17","current":-15.470677,"twenty":-20.105065,"median":-16.579363,"eighty":-15.259057,"marketCap":694076449},{"date":"2026-07-24","current":-15.560103,"twenty":-20.01284,"median":-16.428664,"eighty":-15.247112,"marketCap":698088452},{"date":"2026-07-31","current":-16.9313,"twenty":-19.979303,"median":-16.327675,"eighty":-15.249961,"marketCap":759605825},{"date":"2026-08-07","current":-14.762377,"twenty":-19.930676,"median":-16.460092,"eighty":-15.249961,"marketCap":827475536},{"date":"2026-08-14","current":-15.019457,"twenty":-19.846835,"median":-16.323837,"eighty":-15.098224,"marketCap":841885631},{"date":"2026-08-21","current":-15.651981,"twenty":-19.814976,"median":-16.231773,"eighty":-15.105016,"marketCap":877340489},{"date":"2026-08-28","current":-16.069685,"twenty":-19.737842,"median":-16.133919,"eighty":-15.15457,"marketCap":900754074}],"updateTime":1788227553633},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGP\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622964308","title":"Spyglass Pharma Inc: Q4 Net Loss $5.72 per Basic and Diluted Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622964308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622964308?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:09","pubTimestamp":1774555762,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E128:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896499","title":"SpyGlass Pharma FY2025 net loss widened 36.64% to $39.9 million; loss per share widened to $17.98","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896499?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:09","pubTimestamp":1774555760,"startTime":"0","endTime":"0","summary":"SpyGlass Pharma filed a Form 8-K reporting fourth-quarter and full-year 2025 results and a corporate update, including the completion of its IPO raising USD 172.5 million in gross proceeds and a Nasdaq listing.Cash, cash equivalents and short-term investments were USD 107.4 million at year-end 2025, and the company said its cash position including IPO proceeds is expected to fund planned operations through 2028.R&D expense rose 35.09% to USD 7.7 million in Q4 and increased 46% to USD 29.2 million for FY 2025, driven by hiring clinical and research personnel and initiating registrational Phase 3 trials for the BIM-IOL System.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyglass Pharma Inc. published the original content used to gener","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL8gZ4Dk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896144","title":"Press Release: SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896144","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896144?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555500,"startTime":"0","endTime":"0","summary":"-- Successfully completed Initial Public Offering  in February 2026,-- Phase 3 trials of BIM-IOL System are ongoing, with enrollment underway. 12-Month Phase 1/2 Data of BIM-IOL System. In March 2026, SpyGlass Pharma announced positive topline results from its Phase 1/2 trial of the BIM-IOL System, which evaluated two dose levels of 78-mcg , the intended commercial dose, and 39-mcg  compared to a physician's choice of commercially available monofocal IOLs from Alcon, Bausch + Lomb or Johnson & Johnson with twice-daily administration of timolol eyedrops as the control group . Evaluable patients receiving the BIM-IOL System achieved a time-matched reduction of 34% and 42% in mean IOP from baseline in the high and low dose groups respectively, compared to a 35% reduction in the control group at 8 a.m. Results were similar at the 10 a.m. timepoint. Additionally, 98% of evaluable patients  in the 78-mcg dose group and 96% of evaluable patients  in the 39-mcg dose group were free from all to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618957548","title":"SpyGlass Pharma: Differentiated BIM-IOL Platform and Favorable Risk-Reward Support Buy Rating Ahead of 2028 NDA Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2618957548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618957548?lang=en_us&edition=fundamental","pubTime":"2026-03-11 00:35","pubTimestamp":1773160541,"startTime":"0","endTime":"0","summary":"Yi Chen, an analyst from H.C. Wainwright, has initiated a new Buy rating on SpyGlass Pharma (SGP). Yi Chen has given his Buy rating due to a combin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/spyglass-pharma-differentiated-bim-iol-platform-and-favorable-risk-reward-support-buy-rating-ahead-of-2028-nda-catalyst-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/spyglass-pharma-differentiated-bim-iol-platform-and-favorable-risk-reward-support-buy-rating-ahead-of-2028-nda-catalyst-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618999953","title":"Jefferies Remains a Buy on SpyGlass Pharma (SGP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618999953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618999953?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:55","pubTimestamp":1773147340,"startTime":"0","endTime":"0","summary":"Jefferies analyst Dennis Ding reiterated a Buy rating on SpyGlass Pharma today and set a price target of $62.00. Ding covers the Healthcare sector,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-spyglass-pharma-sgp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-spyglass-pharma-sgp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4585","XLV","SGP","BK4588","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618932921","title":"SpyGlass Pharma Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2618932921","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618932921?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:25","pubTimestamp":1773141900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 10, 2026 07:25 ET (11:25 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618393499","title":"De‑Risking Milestone and Pipeline Catalysts Underpin High‑Risk Buy on SpyGlass Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2618393499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618393499?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:56","pubTimestamp":1773140169,"startTime":"0","endTime":"0","summary":"Citi analyst Yigal Nochomovitz has maintained their bullish stance on SGP stock, giving a Buy rating today. Yigal Nochomovitz has given his Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/de‑risking-milestone-and-pipeline-catalysts-underpin-high‑risk-buy-on-spyglass-pharma-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/de‑risking-milestone-and-pipeline-catalysts-underpin-high‑risk-buy-on-spyglass-pharma-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618939904","title":"SpyGlass Pharma initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2618939904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618939904?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:21","pubTimestamp":1773138075,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Yi Chen initiated coverage of SpyGlass Pharma (SGP) with a Buy rating and $37 price target SpyGlass is a clinical-stage bio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spyglass-pharma-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spyglass-pharma-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618393099","title":"Spyglass Pharma, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618393099","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618393099?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:16","pubTimestamp":1773137783,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nAZN4SKHSL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618762588","title":"Spyglass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative Bim-Iol System","url":"https://stock-news.laohu8.com/highlight/detail?id=2618762588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618762588?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:00","pubTimestamp":1773057600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nTUA8K96XW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618434625","title":"SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System","url":"https://stock-news.laohu8.com/highlight/detail?id=2618434625","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618434625?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:00","pubTimestamp":1773057600,"startTime":"0","endTime":"0","summary":"97% of patients who received the BIM-IOL System off all topical IOP-lowering therapy at 12-months100% of BIM-IOL System patients achieved 20/32 or better BCDVA and a mean BCDVA equivalent to 20/20 vis","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3251760/0/en/SpyGlass-Pharma-Announces-Positive-Topline-12-Month-Phase-1-2-Trial-Results-for-Its-Innovative-BIM-IOL-System.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616558928","title":"SpyGlass Pharma to Host 1x1 Meetings at Jefferies Biotech on the Bay Summit in Miami Beach","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558928","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616558928?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:02","pubTimestamp":1772629358,"startTime":"0","endTime":"0","summary":"SpyGlass Pharma to Host 1x1 Meetings at Jefferies Biotech on the Bay Summit in Miami Beach               SpyGlass Pharma Inc. will host one-on-one meetings at the Jefferies Biotech on the Bay Summit i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL42Kg64:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BGHQF748.EUR","BK4112","BK4007","NDAQ","BK4585","SGP","BK4588","LU2210149790.SGD","LU0314104364.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616632835","title":"SpyGlass Pharma Initiated at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2616632835","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616632835?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:05","pubTimestamp":1772543100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2026 08:05 ET (13:05 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616754347","title":"SpyGlass Pharma: De-risked BIM-IOL Platform Poised to Reshape Glaucoma Treatment and Drive Upside to Conservative Peak Sales Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2616754347","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616754347?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:35","pubTimestamp":1772541342,"startTime":"0","endTime":"0","summary":"Yigal Nochomovitz, an analyst from Citi, has initiated a new Buy rating on SpyGlass Pharma (SGP). Yigal Nochomovitz has given his Buy rating due to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/spyglass-pharma-de-risked-bim-iol-platform-poised-to-reshape-glaucoma-treatment-and-drive-upside-to-conservative-peak-sales-estimates-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/spyglass-pharma-de-risked-bim-iol-platform-poised-to-reshape-glaucoma-treatment-and-drive-upside-to-conservative-peak-sales-estimates-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGP","SKIS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616772342","title":"Leerink Initiates at Outperform With $42 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2616772342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616772342?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:18","pubTimestamp":1772540314,"startTime":"0","endTime":"0","summary":"Leerink Initiates at Outperform With $42 Price Target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616342774","title":"Jefferies Initiates SpyGlass Pharma at Buy With $62 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2616342774","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616342774?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:17","pubTimestamp":1772540250,"startTime":"0","endTime":"0","summary":"Jefferies Initiates SpyGlass Pharma at Buy With $62 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616491513","title":"SpyGlass Pharma initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2616491513","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616491513?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:41","pubTimestamp":1772534482,"startTime":"0","endTime":"0","summary":"Citi initiated coverage of SpyGlass Pharma (SGP) with a Buy rating and $42 price target The firm sees a positive risk/reward despite the stock’s 70...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spyglass-pharma-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spyglass-pharma-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}]}}